Monthly average daily global and diffuse solar radiation based on sunshine duration and clearness index for Brasov, Romania

The main objective of this study is to develop single location appropriate models for the estimation of the monthly average daily global and diffuse horizontal solar radiation for Brasov, Romania. The study focuses particularly on models based on the sunshine duration and clearness index. The data used for the calibration of the models were collected during a period of 4 yr, between November 2008 and October 2012, at the Transilvania University of Brasov. The testing and validation of the models was carried out using data from the online SoDa database for Brasov for the year 2005. Different statistical error tests were applied to evaluate the accuracy of the models. The predicted values are also compared with values from three other known models concerning the global and diffuse solar radiation. A new mixed model was developed for the estimation of monthly average daily global horizontal solar radiation. The data processing was performed by means of a real-time interface developed with LabVIEW graphical programming language. The parameters taken into account were the relative sunshine, the clearness index, the extraterrestrial radiation, the latitude and the longitude. The methodology is simple and effective and may be applied for any region. Its effectiveness was proven through comparison with global models

Designing a smart gateway for data fusion implementation in a distributed electronic system used in automotive industry

This paper focuses on the interdisciplinary research on the design of a smart gateway for managing the dynamic error code testing collected and generated by the Electronic Control Unit (ECU) from the automotive industry. The techniques used to exchange information between the ECU code errors and knowledge bases, based on data fusion methods, allowed us to consolidate and ensure data reliability, and then to optimize processed data in our distributed electronic systems, as the basic state for Industry 4.0 standards. At the same time, they offered optimized data packets when the gateway was tested as a service integrator for ECU maintenance. The embedded programming solutions offered us safe, reliable, and flexible data packet management results on both communication systems (Transmission Control Protocol/Internet Provider (TCP/IP) and Controller Area Network (CAN) Bus) on the Electronic Control Unit (ECU) tested for diesel, high-pressure common rail engines. The main goal of this paper is to provide a solution for a smart, hardware–software, Industry-4.0-ready gateway applicable in the automotive industry

Supported Pt-Rh bimetallic catalysts as efficient systems for methylcyclohexane ring opening

International audienceA series of supported Pt-Rh bimetallic systems was prepared either (i) by the refilling method (a surface redox reaction), or (ii) by the classical coimpregnation or (ii) by mechanical mixture of supported monometallic Pt and Rh catalysts and acidic support (chlorinated alumina). Two oxide supports were used for these preparations, i.e. alumina and silica. All these systems, largely characterized in a previous work dedicated to methylcyclopentane (MCP) hydrogenolysis, were studied for the methylcyclohexane (MCH) ring opening (RO) performed under high pressure (39.5 bar). During MCH transformation, synergetic performances were observed with some supported Pt-Rh bimetallic catalysts, since better performances in terms of activity and RO selectivity were obtained compared to those of monometallic Pt and Rh systems. The metallic particle size acts as a determining parameter modulating the catalytic properties, since the best RO performances were obtained on bimetallic catalysts presenting the largest particle sizes, for which a Pt surface enrichment and the presence of a Pt-Rh alloy were previously detected. On these bimetallic catalysts, the ring opening occurs mainly according to a bifunctional mechanism, the chlorinated alumina support bringing the required acidic function for the first isomerization step of C6 ring to alkylcyclopentanes further opened on the metallic function. The acidic function and the metal sites should not be necessarily in close vicinity since the mechanical mixture of non-acidic Pt-Rh/SiO2 catalyst with chlorinated alumina leads also to high RO selectivities. Finally, as for MCP ring opening, the refilling method allows synthesizing supported bimetallic Pt-Rh catalysts particularly efficient in terms of activity and RO selectivity. (C) 2011 Elsevier B.V. All rights reserved

Abstract LB-118: Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation

Abstract Background: TRK inhibition is now standard of care for advanced pediatric and adult patients (pts) with TRK fusion solid tumors, regardless of origin. To date, TRK kinase domain mutations are the only known resistance mechanism, and next-generation TRK inhibitors active against these mutations such as LOXO-195 are being developed. We reasoned some pts will develop TRK-independent resistance and hypothesized that these pts will require unique therapeutic approaches. Methods: Paired tumor biopsies and serial cell-free DNA (cfDNA) prospectively collected from pts with TRK fusion-positive cancers treated with first- and next-generation TRK inhibitors before treatment and at progression were sequenced. In parallel, pt-derived and engineered models were analyzed. Results: Alterations involving upstream non-TRK receptor kinases and downstream MAPK pathway members were initially identified in tumors from 3 TRK fusion-positive gastrointestinal (GI) cancer pts who developed resistance to TRK inhibitors. Pt 1 with CTRC-NTRK1 pancreatic cancer developed temporally distinct emergent BRAF V600E and KRAS G12D mutations. Pt 2 with LMNA-NTRK1 colorectal cancer developed temporally distinct KRAS G12A and G12D mutations. Pt 3 with PLEKHA6-NTRK1 cholangiocarcinoma developed focal MET amplification. Phenocopying these clinical observations, pt-derived xenografts and primary cell lines developed BRAF and KRAS mutations following chronic TRK inhibition. Consistently, ectopic expression of these alterations conferred resistance to TRK inhibitors. Given that all 3 index pts had GI cancers, we expanded serial cfDNA sequencing to 5 additional TRK fusion-positive GI disease, identifying 3 with emergent MAPK alterations at progression, bringing the overall frequency of acquired MAPK alterations in GI cancers analyzed to 75% (6/8). To further evaluate whether these emergent alterations induced functional dependence on ERK signaling, pts 1-3 were treated with agents targeting these emergent alterations (dabrafenib + trametinib, LOXO-195 + trametinib, and LOXO-195 + crizotinib, respectively). Pt 1 achieved transient tumor regression, followed by outgrowth of KRAS-mutant disease. Pt 3 achieved a 4.5 months tumor regression. Sequencing at progression in pt 3 identified multiple acquired MET point mutations known to interfere with crizotinib binding. Conclusions: These data suggest that a subset of TRK fusion-positive cancers will develop off-target mechanisms of resistance to TRK inhibition. Relative to other TRK fusion-positive tumors, GI cancers may have a higher propensity for developing these bypass alterations that demonstrate remarkable convergence on ERK signaling. A portion of these mechanisms may be managed with simultaneous targeting of the TRK and MAPK pathways, although additional modeling is required to determine if upfront treatment would confer more durable responses. Citation Format: Emiliano Cocco, Amanda Kulick, Sandra Misale, Rona Yaeger, Pedram Razavi, Helen H. Won, Ryan Ptashkin, Jaclyn F. Hechtman, Eneda Toska, James Cownie, Romel Somwar, Sophie Shifman, Marissa Mattar, S Duygu Selçuklu, Aliaksandra Samoila, Sean Guzman, Brian B. Tuch, Kevin Ebata, Elisa de Stanchina, Rebecca J. Nagy, Richard B. Lanman, Michael F. Berger, Marc Ladanyi, David M. Hyman, Alexander Drilon, Maurizio Scaltriti, Alison M. Schram. Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr LB-118